CUMBERLAND PHARMACEUTICALS (CPIX) Stock Price, Forecast & Analysis
USA - NASDAQ:CPIX - US2307701092 - Common Stock
CPIX Key Statistics, Chart & Performance
The current stock price of CPIX is 2.99 USD. In the past month the price decreased by -4.47%. In the past year, price increased by 166.96%.
CPIX Latest News, Press Relases and Analysis
CPIX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 39.24 | 816.66B | ||
| JNJ | JOHNSON & JOHNSON | 18.2 | 454.86B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.56 | 255.48B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.83 | 239.64B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 12.81 | 219.77B | ||
| MRK | MERCK & CO. INC. | 9.87 | 214.76B | ||
| PFE | PFIZER INC | 7.27 | 140.15B | ||
| SNY | SANOFI-ADR | 11.52 | 123.27B | ||
| GSK | GSK PLC-SPON ADR | 7.73 | 94.25B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.02 | 93.77B | ||
| ZTS | ZOETIS INC | 23.17 | 63.86B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 48 | 42.45B |
Related stock screener links
About CPIX
Company Profile
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company is headquartered in Nashville, Tennessee and currently employs 91 full-time employees. The company went IPO on 2009-08-11. The firm is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection, for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative, for the treatment of constipation; Sancuso (granisetron) transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ (telavancin) injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
Company Info
CUMBERLAND PHARMACEUTICALS
1600 West End Avenue, Suite 1300
Nashville TENNESSEE 37203 US
CEO: A. J. Kazimi
Employees: 91
Phone: 18774842700
CUMBERLAND PHARMACEUTICALS / CPIX FAQ
Can you describe the business of CUMBERLAND PHARMACEUTICALS?
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company is headquartered in Nashville, Tennessee and currently employs 91 full-time employees. The company went IPO on 2009-08-11. The firm is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection, for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative, for the treatment of constipation; Sancuso (granisetron) transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ (telavancin) injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
What is the stock price of CUMBERLAND PHARMACEUTICALS today?
The current stock price of CPIX is 2.99 USD. The price decreased by -6.85% in the last trading session.
What is the dividend status of CUMBERLAND PHARMACEUTICALS?
CPIX does not pay a dividend.
What is the ChartMill rating of CUMBERLAND PHARMACEUTICALS stock?
CPIX has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is CUMBERLAND PHARMACEUTICALS (CPIX) stock traded?
CPIX stock is listed on the Nasdaq exchange.
What is the ownership structure of CUMBERLAND PHARMACEUTICALS (CPIX)?
You can find the ownership structure of CUMBERLAND PHARMACEUTICALS (CPIX) on the Ownership tab.
CPIX Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to CPIX. When comparing the yearly performance of all stocks, CPIX is one of the better performing stocks in the market, outperforming 94.47% of all stocks.
CPIX Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CPIX. While CPIX seems to be doing ok healthwise, there are quite some concerns on its profitability.
CPIX Financial Highlights
Over the last trailing twelve months CPIX reported a non-GAAP Earnings per Share(EPS) of 0.14. The EPS increased by 207.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.32% | ||
| ROE | -10.47% | ||
| Debt/Equity | 0.19 |